SEHK:2190Medical Equipment
Zylox Tonbridge Medical Technology (SEHK:2190) Stock Profitability Surge Sharpens Valuation Debate
The market has barely flinched on Zylox-Tonbridge Medical Technology, with the stock around HK$21 after a steady run over the past month, but the latest half-year numbers tell a more forceful story. The headline is earnings power. Basic earnings per share for H1 2026 came in at ¥0.57, backed by ¥632.0m in revenue and a trailing net margin of 25.2%.
For a medical device stock often framed as a growth story, this reporting season is focused on profitability and what a 25.2% margin means for how...